1244 related articles for article (PubMed ID: 25409678)
1. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
2. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.
Quenot JP; Helms J; Bourredjem A; Dargent A; Meziani F; Badie J; Blasco G; Piton G; Capellier G; Mezher C; Rebibou JM; Nadji A; Crepin T; Barbar SD; Fleck C; Cransac A; Boulin M; Binquet C; Soudry-Faure A; Bruyère R;
Ann Intensive Care; 2019 Jul; 9(1):75. PubMed ID: 31264073
[TBL] [Abstract][Full Text] [Related]
3. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
[TBL] [Abstract][Full Text] [Related]
5. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
[TBL] [Abstract][Full Text] [Related]
6. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
Thomson PC; Morris ST; Mactier RA
Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
[TBL] [Abstract][Full Text] [Related]
8. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
9. Exchange over the guidewire from non-tunneled to tunneled hemodialysis catheters can be performed without patency loss.
Park HS; Choi J; Kim HW; Baik JH; Park CW; Kim YO; Yang CW; Jin DC
J Vasc Access; 2018 May; 19(3):252-257. PubMed ID: 29529930
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
[TBL] [Abstract][Full Text] [Related]
11. Non-tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: a prospective cohort study.
Mendu ML; May MF; Kaze AD; Graham DA; Cui S; Chen ME; Shin N; Aizer AA; Waikar SS
BMC Nephrol; 2017 Dec; 18(1):351. PubMed ID: 29202728
[TBL] [Abstract][Full Text] [Related]
12. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
13. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.
Van Hulle F; Bonkain F; De Clerck D; Aerden D; Vanwijn I; Tielemans C; Wissing KM
J Vasc Access; 2019 Jan; 20(1):60-69. PubMed ID: 29893163
[TBL] [Abstract][Full Text] [Related]
15. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
16. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
18. New technology: heparin and antimicrobial-coated catheters.
Ibeas-Lopez J
J Vasc Access; 2015; 16 Suppl 9():S48-53. PubMed ID: 25751551
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of peripherally inserted central venous catheters in acute cardiac care management.
Poletti F; Coccino C; Monolo D; Crespi P; Ciccioli G; Cordio G; Seveso G; De Servi S
J Vasc Access; 2018 Sep; 19(5):455-460. PubMed ID: 29514546
[TBL] [Abstract][Full Text] [Related]
20. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
